Exhaled nitric oxide or FEF_25%-75% Balancing diagnostic value with efficacy despite evidentiary uncertainty

Ann Allergy Asthma Immunol. 2017 Feb;118(2):236-237. doi: 10.1016/j.anai.2016.12.014.

Authors

Andrew S Nickels¹, Kaiser G Lim²

Affiliations

¹ Division of Allergy, Pulmonary, and Critical Care, Department of Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: andrewsnickels@gmail.com.
² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

PMID: 28153083
DOI: 10.1016/j.anai.2016.12.014

No abstract available

Publication types

Letter

MeSH terms

Asthma / diagnosis*
Asthma / drug therapy
Asthma / metabolism
Breath Tests / methods
Child
Exhalation / drug effects
Exhalation / physiology
Female
Humans
Male
Methacholine Chloride / administration & dosage
Nitric Oxide / metabolism*
Respiratory Tract Diseases / diagnosis
Respiratory Tract Diseases / drug therapy
Respiratory Tract Diseases / metabolism
Uncertainty

Substances

Methacholine Chloride
Nitric Oxide